Education
About Us
Working with TipRanks
Follow Us
Brainsway Ltd (IL:BWAY)
:BWAY
BWAY Stock Chart & Stats
2642.00
0.01(0.06%)
At close: 4:00 PM EST
2642.00
0.01(0.06%)
Day’s Range― - ―
52-Week Range1,444.00 - 2,940.00
Previous CloseN/A
Volume32.24K
Average Volume (3M)85.46K
Market Cap
1.08B
Enterprise Value749.92M
Total Cash (Recent Filing)70.46M
Total Debt (Recent Filing)6.75M
Price to Earnings (P/E)44.9
Beta0.03
Next Earnings
Mar 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)13.80
Shares Outstanding39,154,180
10 Day Avg. Volume88,081
30 Day Avg. Volume85,462
Financial Highlights & Ratios
PEG Ratio-0.33
Price to Book (P/B)2.56
Price to Sales (P/S)3.88
P/FCF Ratio24.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Brainsway News
BWAY FAQ
What was Brainsway Ltd’s price range in the past 12 months?
Brainsway Ltd lowest stock price was 1444.00 and its highest was 2940.00 in the past 12 months.
What is Brainsway Ltd’s market cap?
Brainsway Ltd’s market cap is 1.08B.
When is Brainsway Ltd’s upcoming earnings report date?
Brainsway Ltd’s upcoming earnings report date is Mar 11, 2026 which is in 82 days.
How were Brainsway Ltd’s earnings last quarter?
Brainsway Ltd released its earnings results on Nov 11, 2025. The company reported 13.8 earnings per share for the quarter, beating the consensus estimate of N/A by 13.8.
Is Brainsway Ltd overvalued?
According to Wall Street analysts Brainsway Ltd’s price is currently Overvalued.
Does Brainsway Ltd pay dividends?
Brainsway Ltd does not currently pay dividends.
What is Brainsway Ltd’s EPS estimate?
Brainsway Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Brainsway Ltd have?
Brainsway Ltd has 39,154,180 shares outstanding.
What happened to Brainsway Ltd’s price movement after its last earnings report?
Brainsway Ltd reported an EPS of 13.8 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.238%.
Which hedge fund is a major shareholder of Brainsway Ltd?
Currently, no hedge funds are holding shares in IL:BWAY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Brainsway Ltd
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
BWAY Company Deck
BWAY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in revenue and system shipments, successful strategic investments, and improved financial guidance. However, there were increased operating expenses and delays in FDA clearance for a strategic partner's product. Overall, the positives significantly outweigh the negatives.View all IL:BWAY earnings summaries